1. Ganospirones A-G, seven undescribed spiro-meroterpenoids from Ganoderma lucidum and their biological activities.
- Author
-
Li D, Li SH, Gao Q, Luo Q, and Cheng YX
- Subjects
- Mice, Animals, RAW 264.7 Cells, Molecular Structure, Spiro Compounds chemistry, Spiro Compounds pharmacology, Spiro Compounds isolation & purification, Nitric Oxide Synthase Type II antagonists & inhibitors, Nitric Oxide Synthase Type II metabolism, Terpenes pharmacology, Terpenes chemistry, Terpenes isolation & purification, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents chemistry, Anti-Inflammatory Agents isolation & purification, Structure-Activity Relationship, Dose-Response Relationship, Drug, Reishi chemistry, Lipopolysaccharides antagonists & inhibitors, Lipopolysaccharides pharmacology
- Abstract
Ganoderma lucidum, a medicinal mushroom with a long history in traditional Chinese medicine, is widely used for chronic diseases. Ganospirones A-G (1-7), seven pairs of undescribed spiro-meroterpenoids, were isolated from the fruiting bodies of G. lucidum. Their structures including absolute configurations were characterized by using NMR spectroscopic data, ECD computational and X-ray diffraction methods. The anti-inflammatory and anti-renal fibrosis activities of the meroterpenoids 1-7 were tested, and the results revealed that (-)-2 and (+)-2 could inhibit iNOS expression in lipopolysaccharide-induced RAW264.7 cells at 20 μM., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF